Now showing items 1-1 of 1
Characterization of Variants of Unknown Significance (VUS) in BRCA1
Approximately 3%-8% of breast cancer patients carry one defective BRCA1 or BRCA2 allele. While the rise of genetic testing have helped identify BRCA mutation carriers, the implication of certain mutations are still unknown. ...